Sin Nombre virus (SNV) causes hantavirus pulmonary syndrome (HPS), with a high rate of mortality in humans who are infected by the transmission of virus from the natural rodent host. In humans, cytotoxic T lymphocytes (CTL) specific for SNV appear to play an important role in the pathogenicity of HPS. There is a correlation between the frequencies of SNV-specific CTLs and the severity of HPS disease. In order to create a mouse model to study the role of SNV-specific T cells in vivo, T cell responses to SNV nucleocapsid (N) protein in B6.PL Thy1 a /Cy mice (H-2 b )
INTRODUCTION
Sin Nombre virus (SNV) causes hantavirus pulmonary syndrome (HPS), with a case mortality rate of about 38 % (CDC, 2004) . HPS is characterized by fever, myalgia and the rapid onset of capillary leak syndrome with haemoconcentration, thrombocytopenia and pulmonary oedema (Duchin et al., 1994; Jenison et al., 1994) . The mechanisms that cause the capillary leakage are not well understood, but appear to have similarities with processes of dengue haemorrhagic fever (Kurane & Ennis, 1994; Rothman & Ennis, 1999) . In haemorrhagic fever with renal syndrome (HFRS) caused by Puumala virus (PUU), Hantaan virus (HTN) and the other Old World hantaviruses, the capillary leakage develops mainly in the kidney, not in the lung, probably by similar mechanisms (Kanerva et al., 1998; Schmaljohn & Hjelle, 1997; Terajima et al., 2004) .
At autopsy, endothelial cells in HPS patients' lungs are infected with SNV, but are not necrotic (Nolte et al., 1995; Zaki et al., 1995) . HPS patients have very high levels of viraemia at the onset of pulmonary oedema and then rapidly clear virus from plasma, but pulmonary damage persists (Terajima et al., 1999) . These data suggest that the endothelial cells are not directly injured by the cytopathic effect of viral infection. In HPS patients' lungs, CD8
+ T cells are present in infiltrated alveolar walls (Zaki et al., 1995) . A link has been reported between the fatal outcome in HPS and the HLA-B35 allele (Koster et al., 1998) . We isolated several SNV-specific cytotoxic T lymphocyte (CTL) lines restricted by HLA-B35 from HPS patients' blood (Ennis et al., 1997) , and tetramer staining using the CTL epitopes specific for SNV showed that patients with severe HPS have higher frequencies of peptide-specific CD8 + T cells in their blood than patients with moderate HPS (Kilpatrick et al., 2004) . These results suggest that CD8
+ CTLs specific for SNV may play a key role in pathogenicity of SNV to humans.
The natural host of SNV is known to be the deer mouse, Peromyscus maniculatus. The experimental infection of deer mice with SNV showed that virus replication was persistent over 90 days, but no apparent clinical symptom was observed (Botten et al., 2000) . Syrian hamsters infected with Andes virus and Maporal virus, but not SNV, were found to develop disease similar to HPS (Hooper et al., 2001; Milazzo et al., 2002) . On the other hand, CTLs in HTN-infected mice play an important role in protection and recovery from persistent infection (Araki et al., 2003; Asada et al., 1988; Nakamura et al., 1985a, b) . Although CTLs induced by HTN or Seoul virus (SEO) infection are cross-reactive, HTN infection induced a higher CTL response than SEO infection in spite of similar levels of antibody responses to these viruses and virus replication (Asada et al., 1989) . SEO is less pathogenic in humans than HTN, suggesting that the difference in CTL induction might influence their pathogenicity. Although H-2K b -restricted CTL epitopes specific for HTN have been reported (Park et al., 2000) , CTL responses to hantavirus infections including SNV in rodents have not been studied in much detail. Recently, Araki et al. (2003) reported that newborn mice infected with HTN developed virus-specific IFN-c-producing CD8 + T cells in the acute phase, but produced little TNF-a. CTL activity of splenocytes was not detectable in these mice, suggesting that these virus-specific CD8 + T cells may have been functionally impaired (Araki et al., 2003) .
In order to create a mouse model to study the role of SNVspecific T cells in vivo, we identified mouse CTL epitopes specific for SNV nucleocapsid (N) protein, because it seems to be a major target of human CTL (Ennis et al., 1997) , as appears also to be the case for HTN and PUU (Van Epps et al., 1999 ). Cross-reactivity of the identified epitopes was then compared among SNV, HTN and PUU. These results will enable the analysis of the roles of CTL in pathogenicity of hantaviruses in experimental animal models. Recombinant vaccinia viruses. Recombinant vaccinia viruses expressing the N protein of SNV or HTN were constructed as described previously (Ennis et al., 1997; Schmaljohn et al., 1990) . These recombinant viruses were grown and titrated in CV1 cells.
Plasmid DNA. The plasmid pTM1-Nhpsv, carrying the SNV-N protein cDNA (Feldmann et al., 1993) , was provided by Christina F. Spiropoulou. The cDNA fragment was amplified by using PCR from pTM1-Nhpsv and cloned into a mammalian expression vector, pcDNA3.1/Hygro(2) (Invitrogen). For plasmid immunization of mice, the resultant plasmid, pSNVS, was purified using EndoFree Plasmid Giga kit (Qiagen) and then dissolved in 0?85 % saline solution. Expression of SNV N protein from pSNVS was confirmed by immunoprecipitation of pSNVS-transfected COS-7 cells using rabbit anti-SNV serum or a mouse monoclonal antibody specific for hantavirus N protein, GB04-BF07, provided by Patrick C. Stockton and Thomas G. Ksiazek (Ruo et al., 1991; Zaki et al., 1995) .
Peptides. Overlapping peptides of SNV, PUU and HTN N proteins were described previously (Ennis et al., 1997; Van Epps et al., 1999 ; Thy1.1) (4-6 weeks old) were purchased from Jackson Laboratories (Bar Harbor, ME). Mice were intraperitoneally immunized twice with 2610 7 p.f.u. recombinant Vac-SNV-N or wild-type WR strain vaccinia virus at day 0 and 4 weeks. For plasmid injection, mice were intramuscularly injected three times with 100 mg pSNVS in the rear quadriceps at weeks 0, 2 and 4. Seven days after the last immunization, splenocytes were collected, treated with 16 ACK buffer (0?829 % NH 4 Cl, 0?1 % KHCO 3 and 0?0072 % disodium-EDTA) and suspended in RPMI 1640 medium with 10 % heat-inactivated fetal bovine serum (FBS) and 5610 25 M 2-mercaptoethanol (2-ME). All mice were kept in the Animal Facility in the University of Massachusetts Medical School, which is regulated by AWA-1995 , PHS-1986 and MA140-1985 following the AAALAC-1965 guidelines. Anaesthesia provided by ketamine/xylazine and cervical dislocation, which are consistent with the recommendations of the Panel on Euthanasia of the American Veterinary Medical Association, were used.
In vitro stimulation. Collected splenocytes were stimulated with 5-10 mg of each peptide ml 21 in RPMI 1640 medium containing 10 % FBS, 5610
25 M 2-ME and 25 U recombinant human IL2 ml 21 . Culture medium was changed twice a week. Bulk culture 51
Cr-release assays were performed between days 7 and 12 of culture. For establishment of CTL lines, the cells were stimulated with 2500 rad gamma-irradiated spleen cells from non-immune C57BL/6J mice plus 5-10 mg ml 21 of each peptide every 2 weeks.
CTL lines. Peptide-specific CTL lines were established by limiting dilution plating. In vitro-stimulated splenocytes were plated at 0?3, 1, 3, 10 or 100 cells per well with 1610 6 gamma-irradiated splenocytes pulsed with 5 mg ml 21 as feeder cells in a 96-well roundbottom plate (Corning) in 0?2 ml RPMI 1640 with 10 % FBS, 2-ME and human IL2. Medium was replenished twice every week, and wells were restimulated with peptide-pulsed gamma-irradiated feeder cells every 2 weeks. Individual wells were tested for recognition of peptide-pulsed EL-4 cells in a 51
Cr-release assay, and positive wells were expanded and restimulated as described above. Surface expression of CD4 and CD8 was determined by flow cytometry with FITC-conjugated antibodies (BD Pharmingen).
51
Cr-release assay. Target cells were labelled with 0?25 mCi (9?25 MBq) 51 Cr for 60 min at 37 uC. Following labelling, the cells were washed three times and then resuspended at 4610 4 ml 21 in RPMI 1640 containing 10 % FBS. Effector cells were added to 2610 3 target cells per well pulsed with 0?1-10 mg peptide ml 21 in 96-well round-bottom plates at various effector cell : target cell (E : T) ratio. Plates were incubated for 4?5 h at 37 uC, supernatants were harvested (Skatron Instruments) and specific lysis was calculated as (experimental release 2 spontaneous release)/(maximum release 2 spontaneous release)6100 (%). All assays were performed in triplicate. All experiments were performed at least twice. Spontaneous lysis was less than 15 % in all assays.
Enzyme-linked immunospot (ELISPOT) assay for single-cell IFN-c secretion. ELISPOT assays were performed according to the manufacturer's protocol (Mabtech AB). Briefly, 96-well Multiscreen-IP plates (Millipore) were coated with 15 mg rat anti-mouse IFN-c monoclonal antibody (AN-18) ml 21 overnight at 4 uC. Freshly isolated splenocytes were then incubated with or without 4 mg peptide ml 21 or 5 mg concanavalin A (ConA) ml 21 at 37 uC for 2 h and added to the pre-coated plates at 2?5610 5 or 5610 5 cells per well in RPMI 1640 containing 10 % FBS. Plates were incubated for 18-20 h at 37 uC. Biotinylated rat anti-mouse IFN-c monoclonal antibody (R4-6A2) was added and incubated for 2 h at room temperature, followed by the addition of streptavidin-horseradish peroxidase for 1-2 h at room temperature. Spots were stained with Vector NovaRED substrate kit for peroxidase (Vector Laboratories). The precursor frequency was calculated as (no. of spots in experimental well 2 no. of spots in medium-control well)/(total no. of cells per well). Experiments were performed in duplicate or triplicate wells.
RESULTS

Identification of epitopes recognized by CTL
To identify H-2K b -restricted epitopes in the SNV N protein, ten (8-mer) peptides were selected as the highest binders to the H-2K b molecule in the SNV N protein based on the results of a peptide-binding motif search (Table 1; LGAFFSIL 335 (a binding score of 14?5) identified in HTN-infected mice, specific lysis of targets pulsed with any of the other nine peptides including NC327-334 was not detected.
To identify additional epitopes recognized by CTL, we used a library of 15-mer peptides overlapping by 9 aa residues of the SNV N protein (Ennis et al., 1997) . For in vitro stimulation of splenocytes from pSNVS-immunized mice, random pools containing 10 peptides were selected and added to freshly isolated splenocytes as effector cells at a final concentration of 2 mg of each peptide ml
21
. After 7 days of in vitro stimulation, bulk culture CTL assays were performed using EL-4 target cells pulsed with 10 mg of each single peptide ml
. The results indicated that target cells pulsed with at least two peptides, NC217-231 or NC331-335, were killed by in vitro-stimulated splenocytes (24?1 or 21?7 %, respectively) ( Table 1 ; experiment 2). NC94-101 peptidestimulated splenocytes also killed the peptide-pulsed EL-4 cells (21?6 %).
Identification of peptides inducing IFN-c production by ELISPOT assay
To identify peptides that induced IFN-c production, a library of 69 peptides (15-mer) (without NC217-231) was analysed in IFN-c ELISPOT assays. The results showed that at least one peptide, NC175-189, induced significant numbers of IFN-c-producing cells (39 cells per 10 6 splenocytes). However, peptide NC91-105 containing NC94-101 did not induce a significant number of IFN-c-producing cells (2 cells per 10 6 splenocytes).
To confirm whether these identified peptides were recognized by T cells, CTL and ELISPOT assays using these three 15-mer peptides and NC94-101 were performed (Table 2) . C57BL/6J mice were intraperitoneally immunized with 2610 7 p.f.u. of Vac-SNV-N twice and splenocytes were collected 15 days after the second immunization. EL-4 cells pulsed with NC175-189 were specifically killed by splenocytes stimulated with this peptide (20?7 %) and this peptide also induced the largest number of IFN-c-producing cells (82?3 cells per 10 6 splenocytes) of all of the peptides (Table 2) . Although NC217-231, NC331-345 and NC94-101 induced fewer IFN-c-producing cells (12?5, 4?3 and 1?1 cells per 10 6 splenocytes, respectively) than NC175-189, EL-4 cells pulsed with these peptides were specifically lysed by splenocytes stimulated in the bulk culture with the respective peptides (22?5, 14?9 and 22?0 %, respectively). Therefore, these three 15-mer peptides and NC94-101 appeared to contain epitopes recognized by CTL.
Establishment of CTL lines specific for NC91-105, NC175-189, NC217-231 or NC331-345
Although both the recombinant vaccinia virus and plasmid DNA induced CTL against epitopes on SNV N protein in immunized mice, plasmid DNA injection may be more suitable for the establishment of CTL lines because recombinant vaccinia virus expresses many vaccinia virus antigens and induces vaccinia virus-specific CTLs. Therefore, B6.PL Thy1 a /Cy mice were immunized intramuscularly three times with 100 mg plasmid pSNVS every 2 weeks. After bulk cultures of spleen cells stimulated with peptides were confirmed to have significant CTL activity specific for each peptide, a limiting dilution assay (LDA) was carried out. The results indicated that the established CTL lines showed a high level of CTL activity to each of the peptidepulsed EL-4 and MC57G cells (over 50 %) (Table 3) . These CTL lines are positive for CD8 by flow cytometric analysis using anti-mouse CD4 and CD8 antibodies (data not shown). The CTL line to NC331-345 recognized two peptides, NC331-340 and NC332-341, with truncations of one amino acid at the N and C termini of NC331-341, but did not recognize NC332-340 (Table 4 ; experiment 3). A second LDA of this CTL line was carried out to obtain subclones, and four CTL clones, 3G11, 3C11, 3E11 and 3F7, were obtained. Clone 3G11 was used in a CTL assay using EL-4 cells pulsed with each peptide at concentrations of 10, 1 or 0?1 mg ml
Identification of CTL epitopes in the peptides
21
. However, the result of the CTL assay using clone 3G11 was similar to that using the CTL line to NC331-345 (data not shown). Therefore, we concluded that both NC331-340 and NC332-341 might be minimal epitopes.
MHC class I restriction of recognition by CTL lines
We studied the MHC class 
Cross-reactivities of CTL lines among hantaviruses
We next studied the specificity of the CTL lines for other related hantaviruses. Representative data obtained with CTL lines are shown in Table 6 . Since the amino acid sequences of CTL epitopes in SNV NC91-105, NC175-189 and NC217-231 are identical to the respective peptides of PUU, CTL lines established with SNV NC91-105, NC175-189 and NC217-231 killed target cells pulsed with the respective peptide of PUU. However, they did not kill target cells pulsed with HTN NC91-105, NC175-189 or NC217-231. The CTL lines to NC331-345 recognized both the peptides of HTN and PUU a little less than that of SNV, because amino acid sequences of PUU and HTN corresponding to SNV NC331-341 have only one substitution (Table 6 ).
Differences of CTL epitopes between SNV and HTN
Since our established CTL lines could not recognize HTN peptides well, we compared the cross-reactivity of Bold values indicate significant CTL activity (over 15 %). CTL between SNV and HTN N proteins. C57BL/6 mice were intraperitoneally immunized with Vac-SNV-N or Vac-HTN-N twice and an ELISPOT assay was performed using splenocytes pooled from two immunized mice (Fig. 1) . Peptides NC175-189 and NC217-231 of SNV induced IFN-c-producing cells (19?3 and 13?3 per 10 6 splenocytes, respectively) from the Vac-SNV-N-immunized mice (Fig. 1a) , but not the Vac-HTN-N-immunized mice (Fig. 1b) . On the other hand, two peptides, NC217-231 and NC332-346, of HTN induced IFN-cproducing cells (>600 and 22?0 per 10 6 splenocytes, respectively) in Vac-HTN-N-immunized mice (Fig. 1b) , but not in Vac-SNV-N-immunized mice (Fig. 1a) We also performed a CTL assay using in vitro-stimulated splenocytes. Splenocytes from Vac-HTN-N-immunized mice were stimulated in vitro with peptides HTN NC91-105, NC175-189, NC217-231 or NC332-346 and used as effector cells after 7 days in vitro stimulation (Fig. 2) . The results indicate that EL-4 cells pulsed with HTN NC217-231 or NC332-346 were killed by bulk culture of splenocytes stimulated with the respective peptide (34?2 or 24?3 %, respectively), but those pulsed with SNV or PUU peptides were not (less than 15 %). HTN NC332-346 induced significant CTL activity from HTN-N-immunized mice (24?2 %), indicating that this peptide contains a previously unknown CTL epitope specific for HTN.
DISCUSSION
In this study, we identified four H-2 b -restricted CTL epitopes in the SNV N protein, established CTL lines to these peptides and compared the cross-reactivity of CTL responses among prototype hantaviruses. Since peptide NC327-334, 327 LGAFFAIL 334 , has only a single amino acid substitution compared with the H-2K b -restricted epitope, 328 LGAFFSIL 335 , which had been identified in HTN-infected C57BL/6 mice (Park et al., 2000) , we expected this peptide with a very high binding score of 14?520 also to be a CTL epitope specific for SNV. Ten peptides including NC327-334 were synthesized as highest binders to H-2K b , but only one peptide, NC94-101, with a binding score of 3?168, was recognized by CTL in SNV N-immunized mice (Table 1 ; experiment 1). It is possible that this single amino acid substitution (S 332 of HTN to A 332 of SNV) may be crucial for CTL induction. CTL lines NC175-189, NC217-231 and NC331-345 and clone 3G11, specific for NC331-345, were stimulated with 2500 rad gamma-irradiated spleen cells from non-immune C57BL/6J mice plus 5 mg of each peptide ml 21 approximately every 2 weeks over 8 weeks. At 7 days after the last stimulation, CTL assays were performed. To determine CTL activity, EL-4 cells pulsed with or without 10 mg of each peptide ml 21 were used as targets. CTL activity is indicated as: +, significant activity (over 15 %), 2, no significant activity (less than 15 %). E : T ratio=10 : 1 or 20 : 1.
Cell line and clone Peptide Sequence CTL activity
QDMRNTIMASK 2 *CTL clone 3G11 to NC331-345 was also used as an effector cell.
Panels of human CTL lines specific for SNV, HTN and PUU have been established from patients or convalescent donors and characterized (Ennis et al., 1997; Terajima et al., 2002; Van Epps et al., 1999 . Three T-cell epitopes were identified on the SNV N protein (Ennis et al., 1997) . In HTN and PUU, bulk culture of PBMC from all three HTN and 7 of 13 PUU donors, showed high CTL activity to N proteinexpressing cells (Van Epps et al., 1999 , and one murine CTL epitope of SNV, 331 FAILQDMRNTI 341 (Fig. 1 , Table 4 ) (Park et al., 2000) , and one human HLA-A2-restricted CTL epitope of HTN, 334 ILQDMRNTI 342 (Lee et al., 2002) . Although it is not known why these two regions induce CTL activity in humans and mice, this information may be useful for the development of subunit vaccines to induce immune responses including CTLs in human or mouse populations.
ELISPOT assays showed that, of these four peptides, SNV NC175-189 induced the largest number of IFN-c-producing cells from Vac-SNV-N-immunized mice and NC217-331 also induced a significant, but smaller, number of IFN-cproducing cells (Table 2) . However, NC91-105 and NC332-345 did not induce detectable levels of IFN-c-producing cells Table 5 . MHC restriction of CTL activity At 7 days after last stimulation, CTL assays were carried out. Each cell line pulsed with 10 mg of each peptide ml 21 was used as a target. In experiment 2 with NC217-231, percentages of lysis of target cells in the absence of peptide were less than 11 %. NT, Not tested.
CTL line* E : T ratio Specific lysis (%) *Bold values indicate significant CTL activity (over 20 %). Table 6 . Cross-reactivity of CTL lines among three hantaviruses and comparison of sequences at the CTL epitopes
Peptides of SNV, PUU and HTN were based on published sequences. These peptides were 15-mer. The amino acids identical to SNV epitopes are shown by horizontal lines. CTL lines specific for SNV N peptides were tested against EL-4 cells pulsed with SNV, HTN or PUU peptides (10 mg ml 21 ). E : T ratio=10. in spite of the fact that they induced CTL activity (Table 2 and Fig. 1a ), which may be explained by the difference in incubation time with peptides in these two assays (20 h in ELISPOT assay versus 7 days in 51 Cr-release assay). Another possibility is that CTL specific for these two peptides might express cytokines other than IFN-c, for example TNF-a.
Cell line
Cross-reactivity among hantaviruses using the established CTL lines indicated that three of the four CTL lines recognized the highly variable central part of N proteins, and all of them could recognize target cells pulsed with the corresponding peptides of PUU N, but only one CTL line recognized target cells pulsed with a corresponding peptide of HTN N (Table 6 ). This result is consistent with the identity of amino acid sequences of CTL epitopes. When a recombinant vaccinia virus expressing HTN N protein was used to immunize hamsters, they were protected from challenge with HTN and SEO, but not PUU (Chu et al., 1995) . de Carvalho Nicatio et al. (2002) reported that bank voles immunized with purified PUU N protein and Freund's complete adjuvant were completely protected from challenge with PUU and partially protected from challenge with Andes virus, which is similar to SNV. They suggested that cellular immune responses may play a more important role than the humoral immune response in cross-protection elicited by recombinant N protein (de Carvalho Nicacio et al., 2002) . Our present results and previous reports reveal that CTLs specific for SNV N protein are more crossreactive to PUU N than to HTN N and might be more protective against PUU than HTN infections.
In HTN-immunized mice, the number of IFN-c-producing cells induced by the peptide HTN NC217-231 was very large (over 600 cells per 10 6 splenocytes) (Fig. 1) , indicating that the H-2K b -restricted CTL epitope, 221 SVIGFLAL 228 , in this peptide might be immunodominant in CTL induction. The recombinant vaccinia viruses, Vac-SNV-N and Vac-HTN-N, used in this study were based on the WR strain of vaccinia virus, and the recombinant genes were inserted into the thymidine kinase gene locus. However, the HTN and SNV N proteins were transcribed using different promoters, P7.5 and the promoter of the Choristoneura biennis entomopoxvirus spheroidin, respectively. The spheroidin promoter induces significantly higher levels of recombinant protein expression than the P7.5 promoter (Pearson et al., 1991) , suggesting that the HTN N protein might be expressed less in mice than SNV N. However, our ELISPOT assay revealed that HTN N protein seems to induce more IFN-c-producing cells than SNV N protein (Fig. 1) . This result suggests that HTN N protein might induce stronger CTL activity than SNV N protein, irrespective of the amount of protein produced.
Identification of SNV-specific mouse CD8
+ T-cell epitopes is necessary to isolate epitope-specific CD8 + T cells from infected mice using mouse MHC class I dimers or tetramers to study their functionality and TCR usage at the single-cell level. It will be interesting to compare epitope-specific CD8 + T cells in the acute phase in newborn and adult mice were collected from two mice at 21 days after final immunization, pooled and then stimulated with 10 mg of each peptide ml "1 in RPMI 1640 containing 10 % FBS, 25 U human IL2 ml "1 and 5610 "5 M 2-ME for 7 days. EL-4 cells pulsed with or without 10 mg of each peptide ml "1 were used as targets. PUU NC332-346 was not used in this experiment. E : T ratio was 50 : 1.
infected with hantavirus, where differences in CTL activity and TNF-a expression were observed (Araki et al., 2003) .
Recently, we showed by MHC class I tetramer staining that patients with severe HPS have larger numbers of SNVspecific CD8 + T cells in their blood than patients with moderate HPS (Kilpatrick et al., 2004) . It is possible to induce SNV epitope-specific CD8 + T cells in laboratory mice, isolate and culture them ex vivo, and adoptively transfer them into mice in which the SNV N protein is expressed in pulmonary endothelial cells. When the number of CTLs adoptively transferred into mice is large enough, these CTLs may be able to cause capillary leakage by attacking endothelial cells expressing the N protein. These experiments could clarify the role of CTLs in the pathogenesis of HPS. A similar experimental system has been used to analyse the immunopathological mechanism of interstitial pneumonia caused by influenza A virus infection (Enelow et al., 1998) . Syrian hamsters infected with Andes virus and Maporal virus, but not SNV, were found to develop disease similar to HPS (Hooper et al., 2001; Milazzo et al., 2002) , but there are few immunological reagents available to analyse cellular immune responses in Syrian hamsters.
The H-2K b -restricted epitope 94 SSLRYGNV 101 has typical anchor residues at positions 5 (Y) and 8 (V) (Rammensee et al., 1995) , and amino acid changes at positions 2 (S to M) and 4 (R to S) result in the loss of recognition by the specific CTL line (Table 6 ). This epitope was respectively the ninth and second highest binding 8-mer peptide to the H-2 K b molecule predicted by two commonly used MHC-binding motif search programs, HLA Peptide Binding Predictions (http://bimas.dcrt.nih.gov/molbio/hla_bind/) (Parker et al., 1994) and SYFPEITHI (http://www.syfpeithi.de) (Rammensee et al., 1999) in the SNV N protein, which is 428 aa long. Another H-2K b -restricted epitope, 218 PVMGVIGFS 226 , is 9 aa long, instead of 8 aa long typical for H-2K b -restricted epitopes, and does not have typical anchor residues. Amino acid changes at positions 4 (G to S) and 9 (S to L) result in the loss of recognition by the specific CTL line. This 9-mer epitope was not selected by either HLA Peptide Binding Predictions (it did not have a score greater than 1) or SYFPEITHI (this program does not have 9-mer motif for the H-2 K b molecule). The H-2D b -restricted epitope 180 SMPTAQSTM 188 has a typical anchor residue at position 9 (M). An A at position 5 is not a typical anchor residue. Amino acid changes at positions 2, 4 and 8, none of which are at anchor residues, result in loss of recognition by the specific CTL line. This 9-mer epitope was respectively the second and sixth highest binding peptide to the H-2 D b molecule predicted by HLA Peptide Binding Predictions and SYFPEITHI. Identification of these epitopes showed both the usefulness and the limitation of the current MHCbinding motif search programs.
In conclusion, mouse CTL responses to hantaviruses were analysed and defined in this study. The results should be useful for the development of experimental vaccines, the analysis of mechanisms of capillary leakage in HPS model systems and the analysis of the differences in pathogenicity among hantaviruses, including SNV in rodents and humans.
